Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Brain : a Journal of Neurology|January 13, 2011
Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of ageKimford J Meador, Gus A Baker, Nancy Browning, et al.
Epilepsy & Behavior : E&B|May 7, 2011
Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposureKimford J Meador, Gus A Baker, Nancy Browning, et al.
Epilepsy & Behavior : E&B|September 10, 2013
Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6yearsMorris J Cohen, Kimford J Meador, Nancy Browning, et al.
JAMA Pediatrics|June 18, 2014
Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 yearsKimford J Meador, Gus A Baker, Nancy Browning, et al.
The Lancet. Neurology|January 29, 2013
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyKimford J Meador, Gus A Baker, Nancy Browning, et al.
The New England Journal of Medicine|April 17, 2009
Cognitive function at 3 years of age after fetal exposure to antiepileptic drugsKimford J Meador, Gus A Baker, Nancy Browning, et al.
Epilepsy & Behavior : E&B|January 21, 2019
Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational studyMorris J Cohen, Kimford J Meador, Ryan May, et al.
Brain Research. Molecular Brain Research|December 8, 2004
Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1Yang Tang, Aigang Lu, Ruiqiong Ran, et al.
Nature Genetics|November 18, 2014
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsyMikko Muona, Samuel F Berkovic, Leanne M Dibbens, et al.
Nature|August 13, 2013
De novo mutations in epileptic encephalopathies, , Andrew S Allen, et al.
Pageof 11